Grant: Collaborative Health Research Projects
University of Toronto
$118,644.00
Screening technologies for identification of bacterial vascular dissemination inhibitors and testing of novel antibioticcomplementing therapeutic molecules
EF 2013-14
Résumé
The spread of bacteria from the initial site of infection to other parts of the body via the bloodstream (dissemination) isresponsible for most of the mortality caused by bacterial infection. Infectious diseases cost the Canadian economy$3.49B/year. The Canadian biopharmaceutical industry, Industry Canada and CIHR have identified discovery anddevelopment of novel classes of antibacterials and molecules for complementing the action of existing antibiotics as astrategic focus for Canadian innovation and development. Disrupting bacterial dissemination may provide an importantantibiotic-complementing approach for limiting infectious disease progression. The proposed project will develop rapid, lesscostly methods for identifying and characterizing bacterial dissemination inhibitors with potential use as novel treatments forbacterial infections.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
446650-2013
Name nom
Moriarty, Tara
Department département
Dentistry, Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
118644
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
3
Application title
Screening technologies for identification of bacterial vascular dissemination inhibitors and testing of novel antibioticcomplementing therapeutic molecules
Keyword
NSERC
Application summary
The spread of bacteria from the initial site of infection to other parts of the body via the bloodstream (dissemination) isresponsible for most of the mortality caused by bacterial infection. Infectious diseases cost the Canadian economy$3.49B/year. The Canadian biopharmaceutical industry, Industry Canada and CIHR have identified discovery anddevelopment of novel classes of antibacterials and molecules for complementing the action of existing antibiotics as astrategic focus for Canadian innovation and development. Disrupting bacterial dissemination may provide an importantantibiotic-complementing approach for limiting infectious disease progression. The proposed project will develop rapid, lesscostly methods for identifying and characterizing bacterial dissemination inhibitors with potential use as novel treatments forbacterial infections.